FindTrial
Sign In

A study on the association of clinical, pathological parameters and outcome with arsenic levels in patients with gallbladder cancer

A study on association of clinicopathological parameters and prognosis with arsenic levels in patients with gallbladder cancer - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/080586
Enrollment
40
Registered
2025-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C23- Malignant neoplasm of gallbladder

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Piyush Ranjan Sahoo
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients are aged 18 years or older. All patients with histopathology-proven gall bladder cancer.

Exclusion criteria

Exclusion criteria: Patients who are pretreated for gallbladder cancer H/O another primary cancer or multiple primaries. Patients who lost to follow-up or did not consent. Female patients who are pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
To evaluate the association of clinical, pathological, and prognostic markers with arsenic concentration in the blood of patients with GBCTimepoint: At baseline, 3 months and 6 months—

Secondary

MeasureTime frame
To study the demographic and clinicopathological profile of GBC patients. To evaluate the association of clinical and prognostic parameters with overall survival.Timepoint: 3 months and 6 months—

Countries

India

Contacts

Public ContactDr Piyush Ranjan Sahoo

Institute of Medical sciences and SUM Hospital

soumyasurathpanda@soa.ac.in8895370579

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026